Important message from the Ministry of Health on infusion fluids

In view of the increasing demand for infusion fluids both in Poland and in other countries, and the limited possibilities to increase the production of these drugs due to the exhaustion of the manufacturers' production potential, the Minister of Health informs about the current issuance of approvals for the temporary release of medicinal products on the basis of applications from pharmaceutical wholesalers.

As a result, medicinal products in foreign packaging may appear on the market. Pharmacies may order infusion fluids imported from abroad from the following wholesalers that have obtained the relevant approvals:

• Farmacol-Logistics Ltd,
• Centrala Farmaceutyczna CEFARM S.A.,
• InPharm Ltd,
• Interpharma Sp.z.o.o.,
• Polska Grupa Farmaceutyczna S.A.,
• Polska Grupa Farmaceutyczna Aptekarz Sp. z o.o.,
• Polska Grupa Farmaceutyczna Spółka Akcyjna,
• POLYPHARM S.A.,
• SLAWEX Pharmaceutical Distribution Company Ltd,
• Przedsiębiorstwo Produkcyjno-Handlowo-Usługowe SPECJAŁ Sp. z o.o.,
• Przedsiębiorstwo Zaopatrzenia Aptek MULTI PHARME S.A.,
• Salus International Ltd,
• TECHNETSA Ltd,
• TRAMCO Ltd,
• MEDYK-LEK Panek sp. z o.o. sp. k.,
• DOZ Joint Stock Company Direct Limited Partnership,
• Komtur Polska Sp. z o.o.,
• Urtica Ltd,
• MEDIFARM FARMACEUTICAL HURTOWNSHIP Limited Liability Company,
• Lubfarm S.A.,
• PharmaVitae sp. z o.o. sp.k.,
• NOVO S.A.,
• BIALMED Ltd,
• Beata Bogdziewicz-Murmyło AB-MED,
• MEDINN Ltd,
• NEUPHARM Ltd.

It is still possible for any pharmaceutical wholesaler to apply for approval from the Minister of Health for the temporary release of infusion fluids.

Source: MZ